+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biosimilar"

Rituximab Biosimilars Market Report and Forecast 2023-2031 - Product Thumbnail Image

Rituximab Biosimilars Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
Bio-Pharma Market 2025-2029 - Product Thumbnail Image

Bio-Pharma Market 2025-2029

  • Report
  • June 2025
  • 229 Pages
  • Global
From
From
Biosimilar Monoclonal Antibodies (mAbs) Market 2021-2025 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies (mAbs) Market 2021-2025

  • Report
  • July 2021
  • 120 Pages
  • Global
From
From
From
From
Biosimilars - Through the Physician's Lens - Product Thumbnail Image

Biosimilars - Through the Physician's Lens

  • Report
  • March 2025
  • 67 Pages
  • Global
From
From
Loading Indicator

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers. Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more